Stock ALEMBICLTD ALEMBIC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Alembic Limited

Equities

ALEMBICLTD

INE426A01027

Delayed Bombay S.E.
Other stock markets
 10:23:30 26/06/2024 BST 		5-day change 1st Jan Change
109.7 INR -2.34% Intraday chart for Alembic Limited +8.40% +21.02%
05-30 Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets MT
05-13 Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets
Alembic Limited Recommends Dividend for the Year Ended 31 March, 2024
Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Alembic Pharmaceuticals Gets US FDA Tentative Nod for Generic Breast Cancer Treatment
Alembic Limited Announces Cessation of C. P. Buch as an Independent Director
Crisil Keeps AA+ Rating on Alembic Pharmaceuticals' Bank Loans with Stable Outlook
ICRA Affirms AA- Rating on Alembic's Bank Financing; Outlook Stable
Indian shares seen muted tracking broader Asian equities
Alembic Pharmaceuticals Fully Resumes Operations at Manufacturing Unit in South Sikkim, India
Alembic Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q3; EPS Tops Estimates
Alembic Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q3, EPS Beats Estimates
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
Alembic Pharmaceuticals Expects Operations at Sikkim, India Units to Be Restores in Two Months
Alembic Pharmaceuticals Extends Corporate Guarantee to US-Based Arm to Secure Credit
Alembic Pharmaceuticals Logs Slightly Higher Consolidated Profit in Fiscal Q2; EPS Misses Estimates
India's Alembic Pharma Q2 profit roughly in-line with estimates
Alembic Limited Appoints Dr. Girish Hirode as an Independent Director of the Company
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALEMBICLTD Stock
  4. News Alembic Limited
  5. Other languages